Drug therapy safety with patients in facilities of the long-term care
Not Applicable
- Conditions
- All adverse drug events (ADE)!T88.7Unspecified adverse effect of drug or medicament
- Registration Number
- DRKS00004952
- Lead Sponsor
- Private Universität Witten/Herdecke gGmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 889
Inclusion Criteria
Patient consent form. Occurring ADE.
Exclusion Criteria
No patient consent form.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method As primary endpoint of our study, reduction of ADE will be analyzed by comparing 30-day-prevalence of ADE of the pre-interventional assessment versus 6 months after starting the intervention (adjusted for nursing homes).
- Secondary Outcome Measures
Name Time Method As secondary endpoints, newly occurring ADE and number of relevant clinical endpoints (e.g. hospitalization) will be evaluated. After a first survey there will be a second cross-sectional analysis after 6 months and a third survey after 12 months.